Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody
REDWOOD CITY, Calif.,, Aug. 6 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem
cells, today announced the publication in Cell Stem
Cell of data demonstrating potent anti-cancer activity in colon ...
First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
MANCHESTER, England, July 29 /PRNewswire/ -- In what will be the Stem
Cell Awareness Association's ( http://www.stemcellaware.com ) seventh awareness rally, past patients, interested physicians, and prospective patients will meet in Manchester to learn about stem
cell technologies and dis...
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
SUNRISE, Fla., July 28 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the US FDA cleared a p...
Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
MADISON, Wis., July 22 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today the appointment of Junying Yu , Ph.D., as senior research fellow. Her significant body of published research has shown her to be one of the leading stem
cell researchers in the world. Dr....
NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
NEW YORK, July 15 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem
cells for future medical need, was featured on CBS2 News, New York City's local CBS station, on Monday evening July 13 ...
Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
MADISON, Wis., July 15 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it has exclusively in-licensed a US-issued patent portfolio on optimizing the stem
cell differentiation selection process and on using heart cells (cardiomyocytes) in drug testing...
Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
PLYMOUTH, Mass., July 9 /PRNewswire/ -- Harvest Technologies Corp. ( www.harvesttech.com ) announced today that the company sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable...
Cellular Dynamics International Reprograms Blood Cells into Stem Cells
MADISON, Wis., July 8 /PRNewswire/ -- Researchers at Cellular Dynamics International (CDI) report the ability to generate pluripotent stem
cells, which have the ability to generate all tissue types in the body, from very small volumes of ordinary human blood samples. This significant bre...
NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
NEW YORK, June 22 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem
cells for future medical need, was featured in Gene Marcial's prominent Business Week column, "Inside Wall Street," on Jun...
Fallopian tubes offer new stem cell source
Human tissues normally discarded after surgical procedures could be a rich additional source of stem
cells for regenerative medicine. New research from BioMed Central's open access Journal of Translational Medicine shows for the first time that human fallopian tubes are abundant in mesenchymal s...
NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
NEW YORK, June 15 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem
cells for future medical need, announced today it has signed an exclusive 10-year agreement with Enhance BioMedical Holdings...
Assessment of safety and efficacy of human embryonic stem cell therapy
Worcester, MA June 11, 2009 (EurekAlert)--Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem
cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for hu...
Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009
DENVER, June 10 /PRNewswire/ -- Building on the momentum of their previous events, the Stem
Cell Awareness Association ( http://www.stemcellaware.com ) will hold the sixth Stem
Cell Awareness Rally in Denver, Colorado on June 13th, 2009. The group's last event, in Punta Gorda, Florida, drew past a...
New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes
SAN DIEGO, May 28 /PRNewswire/ -- Entest BioMedical, Inc., a newly formed wholly-owned subsidiary of San Diego-based Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today the launch of its Web site ( http://www.EntestBio.com ) to focus on new stem
cell research, includin...
Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
MOUNTAIN VIEW, Calif., May 28 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the upcoming (June 1, 2009) release of the Xfect(TM) and Xfect(TM) Stem
transfection reagents. These novel transfection reagents are based on biodegradable nanop...
RSCI Announces World-Leading Stem Cell Science Advisory Board
The Repair Stem
Cell Institute (RSCI) today announced its 2009 Science Advisory Board. Once again this year, every member of the SAB is a stem
cell world-leader and has a world-first to his credit.
Dallas, Texas (PRWEB) May 27, 2009 -- The Repair Stem
Cell Institute (R...
Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)
The American Stem
Cell Therapy Association (ASCTA) announced today the availability of the world's first clinical guidelines to allow U.S. doctors to safely begin using a patient's own stem
cells to treat disease.
Broomfield, CO (PRWEB) May 19, 2009 -- The American Stem...
Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital
LA JOLLA, Calif., May 15 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has acquired exclusive intellectual property rights jointly owned by Children's Hospital Boston and Massachusetts General Hospital. This intellectual property covers compositions and methods for supportin...
'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher
SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- Dr. Feng Lin, Director of Research at Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN) and Entest BioMedical Inc., today stated that he believes that an effective new therapy for "traumatic brain injury" (TBI) using autologous "adipose-derived...
NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
License Strengthens NeoStem's Portfolio of Regenerative Treatments
NEW YORK, May 11, /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem
cells for future medical need, announced today it ha...
Cord Blood America to Acquire or Build Its Own Stem Cell Laboratory
SANTA MONICA, Calif., May 7 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem
cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem
cells to families nationwide and interna...
Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
SAN DIEGO, May 4 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN)( http://www.BMSN.us ) and Entest BioMedical Inc., its wholly owned subsidiary, announced today they have jointly submitted a Project Summary Report to the U.S. Army Medical Research and Mater...
NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
NEW YORK, May 4 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem
cells for future medical need, announced today it has signed an agreement to license the exclusive worldwide rights to an inno...
Cord Blood America Supports Effort in Congress to Inform on Value of Umbilical Cord Blood Stem Cell Storage
SANTA MONICA, Calif., April 30 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem
cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem
cells to families nationwide and inte...
STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells
STEMCELL Technologies, Inc. today announced the release of MesenCult®-ACF Medium , the first defined, animal component-free (ACF) and serum-free medium for culturing human mesenchymal stem
Vancouver, B.C. (PRWEB) April 28, 2009 -- STEMCELL Technol...
Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
Catalyst to Provide Proprietary Protein and Small Molecule Products for the Generation and Differentiation of Genomically-Unaltered Induced Pluripotent Stem
LA JOLLA, Calif. and BOSTON, April 23 /PRNewswire/ -- Fate Therapeutics, Inc. and Stemgent, Inc. announced today the...
China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility
TAIZHOU, Jiangsu, China, April 22 /PRNewswire-Asia/ -- Jiangsu
government's China Medical City (CMC) and Shenzhen Beike Biotechnology Co. Ltd.
( http://www.beikebiotech.com ) broke ground on the 20,000 square-meter Stem
Cell Regenerative Medicine Industrial Project of National Bio-Industry Ba...
Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
DENVER , April 22 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, yesterday presented data at the annual meeting of the American Association for Canc...
FRC: NIH Stem Cell Guidelines Reflect Poor Science, Ignore Real Hope for Patients
WASHINGTON, April 17 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) issued draft guidance for implementing President Obama's executive order to fund embryonic stem
cell research (ESCR). President Obama's decis...
Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program
ST. JOSEPH, Mich., April 14 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Professor Marcelo Bento Soares of Children's Memorial Research Center has joined the MetaMiner Stem
Cell Partnership Program. The goal of the program is to develop a series ...
ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
RANCHO CORDOVA, Calif., April 2 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem
cells, said today that its devices will be the subject of several scientific abstracts to be presented at the ...
Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial
Central Texas man receives groundbreaking therapy days after heart attack
AUSTIN, Texas, March 31 /PRNewswire/ -- On March 30, the Heart Hospital of Austin treated the first patient in the world enrolled in a groundbreaking Phase II study designed to test the effectiveness and safety of a...
Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies
WASHINGTON, March 31 /PRNewswire-USNewswire/ -- For the first time, scientists have shown that amniotic fluid (the protective liquid surrounding an embryo) may be a potential new source of stem
cells for therapeutic applications. The study was prepublished online on February 12, 2009, in Blood , ...
ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit
ATHENS, Ga., March 31 /PRNewswire/ -- ArunA Biomedical, Inc., a leader in human embryonic stem
cell derived products, announced today that it has co-developed a validated kit to produce induced pluripotent stem
cells with Open Biosystems now part of Thermo Fisher.
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
RSCI's Chairman expressed his concern that since few people can afford to travel outside the country for medical treatments, America needs to put more focus on approving ultra safe adult stem
cell treatments to alleviate the suffering of millions diagnosed with so-called untreatable diseases.
Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
A Complimentary Webinar
MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --
- TOPIC: The state of the microRNA market and the molecule's
current and potential impact on drug discovery, molecular
diagnostics, and personalized therapeutics.
ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
ATHENS, Ga., March 27 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its CELL-EZ(TM) brand hMC(TM) human mesenchymal progenitor cells commercially available to the research community in mid 2009. Derived from pluripotent human embryonic stem
cells, ArunA's hMC lines wil...
NIH News Confirms Trend in Stem Cell 'Storage' Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today that the important discovery reported on Wednesday, March 25 by researchers at the National Institutes of Health (NIH; www.nih...
Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview
SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), told the editors of The Wall Street Transcript, a New York City financial news weekly, that there is an excellent possibility that the company ...
Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products
- Stemgent to provide CellDesign's proprietary adipocyte differentiation kits -
SAN DIEGO and NEW HAVEN, Conn., March 24 /PRNewswire/ -- Stemgent has signed a co-exclusive license to market CellDesign's AdipoDesign Starter Kit and AdipoDesign MaxiKit, which enable researchers to grow and stud...